Prediction of patient outcome from Acinetobacter baumannii bacteremia with sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation (APACHE) II scores

Internal Medicine

Volumn 50, Issue 8, 2011, Pages 871-877

  Chen, Su Jung ^a,b   Chao, Tze Fan ^b   Chiang, Mei Chun ^b   Kuo, Shu Chen ^a,b   Chen, Liang Yu ^b   Yin, Ti ^a   Chen, Te Li ^a,b   Fung, Chang Phone ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acinetobacter baumannii; APACHE score; Bacteremia; Outcome; SOFA score

Indexed keywords

ACINETOBACTER INFECTION; AGED; APACHE; ARTICLE; BACTEREMIA; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREDICTION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEQUENTIAL ORGAN FAILURE ASSESSMENT; SURVIVAL TIME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; APACHE; BACTEREMIA; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TAIWAN; TREATMENT OUTCOME;

EID: 79955557656     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4312     Document Type: Article

References (36)

1. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 8: 687-693, 2002.
2. Eveillard M, Soltner C, Kempf M, et al. The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. J Infect 60: 154-161, 2010.
3. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 74: 340-349, 1995.
4. Moreno S, Vicente T, Armas M, Bernaldo de Quiros JC, Rodriguez-Creixems M, Bouza E. Nosocomial bacteremia caused by Acinetobacter. Enferm Infecc Microbiol Clin 8: 606-609, 1990.
5. Cisneros JM, Reyes MJ, Pachon J, et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 22: 1026-1032, 1996.
6. Tilley PA, Roberts FJ. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis 18: 896-900, 1994.
7. Chiang DH, Wang CC, Kuo HY, et al. Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification. J Microbiol Immunol Infect 41: 397-402, 2008.
8. Metan G, Sariguzel F, Sumerkan B. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur J Intern Med 20: 540-544, 2009.
9. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710, 1996.
10. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23: 1638-1652, 1995.
11. Le Gall Jr, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276: 802-810, 1996.
12. Kajdacsy-Balla Amaral AC, Andrade FM, Moreno R, Artigas A, Cantraine F, Vincent JL. Use of the sequential organ failure assessment score as a severity score. Intensive Care Med 31: 243-249, 2005.
13. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26: 1793-1800, 1998.
14. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 25: 686-696, 1999.
15. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286: 1754-1758, 2001.
16. Zygun DA, Laupland KB, Fick GH, Sandham JD, Doig CJ. Limited ability of SOFA and MOD scores to discriminate outcome: a prospective evaluation in 1,436 patients. Can J Anaesth 52: 302-308, 2005.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829, 1985.
18. Oh TE, Hutchinson R, Short S, Buckley T, Lin E, Leung D. Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Crit Care Med 21: 698-705, 1993.
19. Rowan KM, Kerr JH, Major E, McPherson K, Short A, Vessey MP. Intensive Care Society's Acute Physiology and Chronic Health Evaluation (APACHE II) study in Britain and Ireland: a prospective, multicenter, cohort study comparing two methods for predicting outcome for adult intensive care patients. Crit Care Med 22: 1392-1401, 1994.
20. Livingston BM, MacKirdy FN, Howie JC, Jones R, Norrie JD. Assessment of the performance of five intensive care scoring models within a large Scottish database. Crit Care Med 28: 1820-1827, 2000.
21. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 34: 1297-1310, 2006.
22. Vincent JL, Ferreira F, Moreno R. Scoring systems for assessing organ dysfunction and survival. Crit Care Clin 16: 353-366, 2000.
23. Choi JY, Park YS, Kim CO, et al. Mortality risk factors of Acinetobacter baumannii bacteraemia. Intern Med J 35: 599-603, 2005.
24. Smolyakov R, Borer A, Riesenberg K, et al. Nosocomial multidrug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54: 32-38, 2003.
25. Brahmi N, Beji O, Abidi N, et al. Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICU in Tunisia, where this pathogen is endemic. J Infect Chemother 13: 400-404, 2007.
26. Chen TL, Siu LK, Wu RC, et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 13: 801-806, 2007.
27. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Twentieth Informational Supplement M100-S20. 2010.
28. Chen HP, Chen TL, Lai CH, et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 38: 127-136, 2005.
29. American College of Chest. Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874, 1992.
30. Camins BC, King MD, Wells JB, et al. The Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol 30: 931-938, 2009.
31. Valero C, Garcia Palomo JD, Matorras P, Fernandez-Mazarrasa C, Gonzalez Fernandez C, Farinas MC. Acinetobacter bacteraemia in a teaching hospital, 1989-1998. Eur J Intern Med 12: 425-429, 2001.
32. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115: 92-106, 1982.
33. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36, 1982.
34. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843, 1983.
35. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 73: 503-508, 2006.
36. Youden WJ. Index for rating diagnostic tests. Cancer 3: 32-35, 1950.